. .
.
. Mayo Clinic Health Solutions
.
. .
.

Browse Categories:
  arrow Research Tools
arrow
  arrow Diagnostics
arrow
  arrow Therapeutics
arrow
  arrow Medical Devices
arrow
  arrow Electronic Devices
arrow
  arrow Software
arrow
  arrow All Listings
arrow
arrow
  Home
arrow
  About Us
arrow
  Contact Us
arrow
arrow
  Go to mayoclinic.org
arrow
  Go to Research at Mayo Clinic
arrow
Mayo Clinic Technology
.

Regulation of Toll-like Receptors by Complex Saccharides

Reference #:

2001-091

Inventors/Contributors

Jeffrey L. Platt M.D., Gregory J. Brunn Ph.D., Yuzo Kodaira M.D., Ph.D., Geoffrey B. Johnson M.D., Ph.D.

Description

We have discovered that complex saccharides, specifically heparan sulfate glycosaminoglycans, signal cells through toll-like receptors. Since toll-like receptors are thought to detect toxic compounds such as endotoxin, the finding that an endogenous saccharide can signal cells through those receptros provides a potentially non-toxic means by which cells can be stimulated. Signaling of toll-like receptors by heparan sulfate might be used to stimulate immunity, prevent cellular injury by infectiuos microorganisms or potentially suppress immune responses.

Patent Status

Pending

Contact

Nathan L. Stacy, Licensing Manager
stacy.nathan@mayo.edu

Mayo Foundation for Medical Education and Research
Office of Technology Commercialization
Centerplace 4
200 First Street SW
Rochester, MN 55905

Phone: (507) 538-1652
Fax: (507) 284-5410